ADVERTISEMENT
Posted: Nov 7, 2021

Bracing for this year's flu season with COVID-19 still taking a toll

On The Cover

We averted the “twindemic” last year, but as hospitalizations from the COVID-19 Delta variant have increased, experts are feeling certain the country could be in for a difficult influenza cycle that could strain the health care system.

Loren Bonner

Read more
Posted: Nov 7, 2021

Silver linings: Pharmacists share stories of gratitude from the COVID-19 pandemic

Well-Being

As the holiday season approaches, pharmacists and their patients find themselves, like everyone, sandwiched between the grief brought on by the ongoing COVID-19 pandemic and the gratitude and thanksgiving of the upcoming holiday.

Sonya Collins

Read more
Posted: Oct 7, 2021

Avoiding “group libel” in public explanations of an adverse drug event

On The Docket

Most adverse drug events are handled internally by the hospital or pharmacy where they occur. The results may be tragic and the risk of legal liability may be significant, yet the incident is not newsworthy. There is no report in the media, and there is no need for a public explanation.

David B. Brushwood, BSPharm, JD

Read more
Posted: Oct 7, 2021

Pharmacy staff can be involved in improving workplace well-being

Wellness

Pharmacists are experiencing high levels of occupational stress, burnout, and moral distress, and the COVID-19 pandemic has only exacerbated this trend.

Loren Bonner

Read more
Posted: Oct 7, 2021

More states make gabapentin a Schedule V Controlled Substance

Gabapentin

Gabapentin has landed on Schedule V Controlled Substance lists in 7 states over the last 5 years. During that same time period, 12 other states have placed the drug in their prescription drug monitoring programs (PMP).

Loren Bonner

Read more
First5354555658606162Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT